Cargando…

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma

The incidence of metastatic pheochromocytoma (PHEO) and paraganglioma (PGL) may occur in as many as 35% of patients particularly with PGL and even more frequently in those with specific mutations. Biochemical, morphological, and molecular markers have been investigated for use in the distinction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilanchezhian, Maran, Jha, Abhishek, Pacak, Karel, Del Rivero, Jaydira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456409/
https://www.ncbi.nlm.nih.gov/pubmed/32862332
http://dx.doi.org/10.1007/s11864-020-00787-z